Chemotherapy and cognitive impairment: treatment options. - Wikidata - wikimedia - TriplyDB

Chemotherapy and cognitive impairment: treatment options.

Chemotherapy and cognitive impairment: treatment options.

http://www.wikidata.org/entity/Q37911248

about

Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment Chemotherapy-related changes in cognitive functioning.Prevalence, mechanisms, and management of cancer-related cognitive impairment.Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults Psychological intervention for improving cognitive function in cancer survivors: a literature review and randomized controlled trial.Nuclear mapping of nanodrug delivery systems in dynamic cellular environments Potential factors associated with perceived cognitive impairment in breast cancer survivors.PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth Advanced cognitive training for breast cancer survivors: a randomized controlled trial.YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and Sleep Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats.Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?Brief self-report measure of work-related cognitive limitations in breast cancer survivors.Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy.Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats.Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats.Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia.Optimizing cancer care: is the future bright?Dimensions and predictors of disability-A baseline study of patients entering somatic rehabilitation in secondary care.Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?Low Serum Carotenoids Are Associated with Self-Reported Cognitive Dysfunction and Inflammatory Markers in Breast Cancer Survivors

P2860

Q24193350-13E7AA28-038E-4515-984E-23BF3D335151 Q26470426-7620A3C9-3B9B-48FE-9383-979279D3F32D Q33697950-94A7A4E1-D24B-43EA-B1CA-1C2D713AE833 Q33854977-E707AD21-7F95-4CDD-A380-41EC87CDDB47 Q34031141-29E543BE-AA3E-4CEF-A497-2DA37269F4F3 Q34395112-446C2DCC-0732-4DCB-A967-97D3689DE266 Q34604438-FA7B6BD5-85AF-46DC-9916-BE9A010FC412 Q35164117-94DD68D3-AADC-4E50-9B12-4193251218C0 Q35215913-C1FBF5F9-B986-4D59-8747-E472F7E1AB5F Q36060654-788689C3-B9EA-4176-8519-9038EC760E46 Q36101338-2B928DB9-32B4-4364-AE87-08840433DD12 Q36310404-5D7BDA7F-7752-4EE2-915E-CB72D491A1D9 Q36914392-E76E003A-74A8-47F5-A277-87F6CC86B877 Q36945894-3F9549C2-5B9C-4B88-9D57-101A81DB5B61 Q37431101-61F68910-FFAF-4653-AACB-0E542F3B3B4F Q37742058-5629090E-2320-4F1B-8E7B-07E617016CD2 Q38161296-A21C0F6E-3E5E-40D3-87A1-5AE46E4D99F1 Q38344507-515DB37E-C696-4BB0-96A2-592AC19312E3 Q44165418-C0DD9055-5698-474D-BFB9-FC950A24B6FB Q44287983-DE6A8DE6-F467-4922-89AA-55E27F6DF7C0 Q46512741-859CDA93-9B88-40EA-9023-6447489952F6 Q47745329-61D97DB9-A40D-4DA3-8196-2A8C3FA32E90 Q47966922-A0D4BC3A-7BD4-420A-824E-4062CB45A372 Q50702535-F35332B2-3EB1-402E-ADC4-0B2E350A8910 Q50914949-69F28850-44C2-4BDD-807B-C14F70F887A2 Q51684485-BA5DDB5E-D2D1-4CFB-9AE6-5589B8A2E667 Q54974899-A0CE9A0A-171D-4EAF-AA54-D5BE300719B2 Q56520646-1F068B54-2312-4C42-9A9F-4C4A1FF1585C Q57168822-D0AFFEF9-7AE3-4329-ACC4-36BE58685543

P2860

Chemotherapy and cognitive impairment: treatment options.

http://www.wikidata.org/entity/Q37911248

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chemotherapy and cognitive impairment: treatment options.

@en

Chemotherapy and cognitive impairment: treatment options.

@nl

type

label

Chemotherapy and cognitive impairment: treatment options.

@en

Chemotherapy and cognitive impairment: treatment options.

@nl

prefLabel

Chemotherapy and cognitive impairment: treatment options.

@en

Chemotherapy and cognitive impairment: treatment options.

@nl

P1433

Q37911248-BCF9A441-3305-4249-BB9F-4C2D0E8BE11E

P1476

Q37911248-5BA56F0D-B572-46B9-9541-443262A84BC5

P2093

Q37911248-3A9C1CF3-8620-463E-8D69-FEC3E80ECD53

Q37911248-5B1C4C92-7FBB-4218-AF97-05344340F470

Q37911248-9C734D6E-1B96-45F1-8F43-B310F723E3CD

Q37911248-AAAD92D4-B6FA-4F07-851C-1EB5B763ADC6

P2860

Q37911248-044EB56D-FF9A-4DE0-9C0A-B9E0E9BD876D

Q37911248-051829F7-729D-4AB2-8F23-9088F6241EB9

Q37911248-07B179D3-70BF-4A7E-AD04-DB526F26CC8F

Q37911248-0D6CB169-FF4C-4FC6-96DD-D8230BA983EF

Q37911248-0E29F5EB-3011-43EC-9823-301A5854DBEA

Q37911248-19F32AC4-576A-4EA6-9725-A99C1600209F

Q37911248-224D6596-2BB7-481A-AA8E-8A7025595674

Q37911248-228DBB07-86D0-4543-A3A0-3558C6CBDE64

Q37911248-25A47B4F-78C1-4911-888E-F41FB37BD83D

Q37911248-26A6F644-C128-4634-B818-5880F33224E8

P2888

Q37911248-1A7020FF-D8AC-4246-B9B0-56C3A0F2C517

P304

Q37911248-C59030E9-59CE-45C0-A4A8-63992AD8A208

P31

Q37911248-98A46C8B-B80F-438F-B444-EDF423FFC862

P356

Q37911248-96024DDA-1E36-4382-B0C9-018595D19AA9

P407

Q37911248-CE46E99E-88A6-45D8-B08D-366F6E87AF7C

P433

Q37911248-C2D3E117-93F5-4ECC-9418-7D4FBD48CD53

P478

Q37911248-89719E41-C0F2-4AF8-84A0-18275E820804

P577

Q37911248-42DC1C4F-B07C-42F3-9F48-C2EA8F8E94BB

P5875

Q37911248-9658E861-DF88-4A28-953A-C75BD99C38D7

P6179

Q37911248-054D81AA-8CEE-478C-B16E-378F050BF892

P698

Q37911248-04DD3F46-504F-484A-905D-96B6EA878EB6

P921

Q37911248-F5051FE9-487C-440E-A3BF-95423CF20403

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Chemotherapy and cognitive impairment: treatment options.

@en

P2093

G Winocur

http://www.w3.org/2001/XMLSchema#string

I N Johnston

http://www.w3.org/2001/XMLSchema#string

J E Fardell

http://www.w3.org/2001/XMLSchema#string

J Vardy

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

Cognitive impairment following high fat diet consumption is associated with brain inflammation.

Cytokines and their relationship to the symptoms and outcome of cancer.

Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.

Fitness effects on the cognitive function of older adults: a meta-analytic study.

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

P2888

P304

366-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2011.112

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51545043

http://www.w3.org/2001/XMLSchema#string

P6179

1001328572

http://www.w3.org/2001/XMLSchema#string

P698

21814191

http://www.w3.org/2001/XMLSchema#string

P921